Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study

References

• Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363: 474–81
   PubMed Web of Science ®Google Scholar
• Seaworth BJ. Multidrug-resistant tuberculosis. Infect Dis Clin North Am 2002; 16: 73–105
   PubMed Web of Science ®Google Scholar
• Geerligs WA, van Altena R, de Lange WCM, van Soolingen D, van der Werf TS. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Int J Tuberc Lung Dis 2000; 4: 758–64
   PubMed Web of Science ®Google Scholar
• Telzak EE, Sepkowitz K, Alpert P, Mannheimer S, Medard F, El-sadr W, et al. Multidrug-resistant tuberculosis inpatients without HIV infection. N Engl J Med 1995; 333: 907–11
   PubMed Web of Science ®Google Scholar
• Escudero E, Pena JM, Alvarez-Sala R, Vazquez JJ, Ortega A. Multidrug-resistant tuberculosis without HIV infection: success with individualized therapy. Int J Tuberc Lung Dis 2006; 10: 409–14
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000 – 2004. MMWR Morb Mortal Wkly Rep 2006;55:301–5.
   PubMedGoogle Scholar
• Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, et al. Treatment of multidrug-resistant tuberculosis (MDR-TB) in Iran. Int J Infect Dis 2005; 9: 317–22
   PubMed Web of Science ®Google Scholar
• Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, et al. Extensively drug-resistant tuberculosis: 2 y of surveillance in Iran. CID 2006; 43: 841–7
   PubMed Web of Science ®Google Scholar
• Caminero JA, World Health Organization, American Thoracic Society, British Thoracic Society. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829–37.
   PubMed Web of Science ®Google Scholar
• Caminero JA. Management of multidrug-resistant tuberculosis and patients in retreatment. Eur Respir J 2005; 25: 928–36
   PubMed Web of Science ®Google Scholar
• Kim SJ. Drug susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 2005; 25: 564–9
   PubMed Web of Science ®Google Scholar
• Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784–91
   PubMed Web of Science ®Google Scholar
• Chiang CY, Enarson DA, Yu MC, Bai KJ, Huang RM, Hsu CJ, et al. Outcome of pulmonary multidrug-resistant tuberculosis: a 6-y follow-up study. Eur Respir J 2006; 28: 980–5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the programmatic management of drug resistant tuberculosis. WHO/HTM/TB/2006; 361.GenevaSwitzerland: WHO 2006.
   Google Scholar
• van Deun A, Salim MA, Das AP, Bastian I, Portaels F. Results of a standardized regimen for multidrug-resistant tuberculosis in Bangladesh. Int J Tuberc Lung Dis 2004; 8: 560–7
   PubMed Web of Science ®Google Scholar
• Suarez PG, Floyd K, Portocarrero J, Alarcón E, Rapiti E, Ramos G, et al. Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 2002; 359: 1980–9
   PubMed Web of Science ®Google Scholar
• Tahaoglu K, Törün T, Sevim T, Ataç G, Kalyoncu A, Karasulu L, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001; 345: 170–4
   PubMed Web of Science ®Google Scholar
• Leimane V, Riekstina V, Holtz T, Zarovska E, Skripconoka V, Thorpe LE, et al. Clinical outcome of individualized treatment of multidrug resistant tuberculosis in Latvia: an retrospective cohort study. Lancet 2005; 365: 318–26
   PubMed Web of Science ®Google Scholar
• Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blondal K, et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 2006; 12: 1389–97
   PubMed Web of Science ®Google Scholar
• Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcantara F, et al. Community based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119–28
   PubMed Web of Science ®Google Scholar
• Bedi RS. Saving quinolones for tuberculosis. J Assoc Physicians India 2003; 51: 933–4
   PubMedGoogle Scholar
• Agarwal A. TB should be diagnosed before using a fluoroquinolone. Br Med J 2003; 327: 164–5
   PubMed Web of Science ®Google Scholar